ZYME
USDZymeworks Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$18.390
最高价
$18.770
最低价
$18.000
成交量
0.08M
公司基本面
市值
1.4B
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
0.66M
交易所
NMS
货币
USD
52周价格范围
相关新闻
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancer64% overall
HC Wainwright & Co. Upgrades Zymeworks to Buy, Raises Price Target to $26
HC Wainwright & Co. analyst Robert Burns upgrades Zymeworks from Neutral to Buy and raises the price target from $13 to $26.
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, and non-small cell lung
B. Riley Securities Initiates Coverage On Zymeworks with Buy Rating, Announces Price Target of $30
B. Riley Securities analyst Mayank Mamtani initiates coverage on Zymeworks with a Buy rating and announces Price Target of $30.
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the
相关股票
LGI
Lazard Global Total Return and Income Fund
SOJD
Southern Company (The) Series 2020A 4.95% Junior Subordinated Notes due January 30 2080
HYFM
Hydrofarm Holdings Group Inc.
NPABU
New Providence Acquisition Corp. II Unit
PYN
PIMCO New York Municipal Income Fund III Common Shares of Beneficial Interest
保持更新
设置价格提醒，获取AI分析更新和实时市场新闻。